Black Rock Inc. Night Hawk Biosciences, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Night Hawk Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 396,695 shares of NHWK stock, worth $63,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares

396,695

Previous 396,707 0.0%

Holding current value

$63,471

Previous $174,000 63.79%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.15 - $0.45 $1 - $5	-12 Reduced -0.0%	396,695 $63,000
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.51 $3,226 - $6,328	-12,408 Reduced 3.03%	396,707 $174,000
Q3 2023 Nov 13, 2023	BUY	$0.5 - $0.72 $51 - $73	102 Added 0.02%	409,115 $216,000
Q2 2023 Aug 11, 2023	SELL	$0.62 - $0.87 $35,496 - $49,809	-57,252 Reduced 12.28%	409,013 $274,000
Q1 2023 May 12, 2023	BUY	$0.83 - $1.24 $1,403 - $2,096	1,691 Added 0.36%	466,265 $405,000

Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.62 $800 - $1,683	1,039 Added 0.22%	464,574 $376,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $3,252 - $5,378	-1,817 Reduced 0.39%	463,535 $802,000
Q2 2022 Aug 12, 2022	SELL	$1.65 - $3.13 $10,820 - $20,526	-6,558 Reduced 1.39%	465,352 $1.19 Million
Q1 2022 May 12, 2022	SELL	$2.1 - $3.54 $6,237 - $10,513	-2,970 Reduced 0.63%	471,910 $1.44 Million
Q4 2021 Feb 10, 2022	SELL	$3.04 - $6.01 $2,112 - $4,176	-695 Reduced 0.15%	474,880 $1.44 Million
Q3 2021 Nov 09, 2021	SELL	$5.9 - $7.44 $21,068 - $26,568	-3,571 Reduced 0.75%	475,575 $2.83 Million
Q2 2021 Aug 11, 2021	BUY	$5.78 - $9.6 $2.77 Million - $4.6 Million	479,146 New	479,146 $3.22 Million

Others Institutions Holding NHWK

# of Institutions

Shares Held

2.21M

Call Options Held

Put Options Held

View Full List

About NightHawk Biosciences, Inc.

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

More about NHWK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account